Terms of Use

Welcome to a website of Mirum Pharmaceuticals, Inc. (“Mirum”). By using the site, you agree to be bound by the following terms and all applicable laws and regulations. Without notice to you, these Terms of Use may be revised at any time, new conditions for use of this website may be imposed, or access may be restricted to some parts of this website. If you do not agree to these Terms of Use, you are not permitted to use the site. The information provided on this website is presented in summary form, is general in nature, and is provided for informational purposes only.

THIS SITE AND THE CONTENT ARE PROVIDED “AS IS”. MIRUM, ITS LICENSORS, AND ITS SUPPLIERS, TO THE FULLEST EXTENT PERMITTED BY LAW, DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR PARTICULAR PURPOSE. SPECIFICALLY, MIRUM, ITS LICENSORS, AND ITS SUPPLIERS MAKE NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS, CURRENTNESS, SUITABILITY OR TIMELINESS OF THE CONTENT, SOFTWARE, TEXT, GRAPHICS, TOOLS, LINKS, OR COMMUNICATIONS PROVIDED ON OR THROUGH THE USE OF THE WEBSITE OR MIRUM, OR ON ANY SITE OR SITES “LINKED” TO THIS SITE. MIRUM MAKES NO WARRANTY THAT THE SITE WILL BE AVAILABLE, UNINTERRUPTED, ERROR FREE, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS.

TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL MIRUM, ITS LICENSORS, ITS SUPPLIERS, OR ANY THIRD PARTIES MENTIONED ON THE WEBSITE BE LIABLE FOR ANY DAMAGES (INCLUDING, WITHOUT LIMITATION, INCIDENTAL AND CONSEQUENTIAL DAMAGES, PERSONAL INJURY/WRONGFUL DEATH, LOST PROFITS, OR DAMAGES RESULTING FROM LOST DATA OR BUSINESS INTERRUPTION) RESULTING FROM THE USE OR INABILITY TO USE THE WEBSITE OR THE CONTENT OR ANY FAILURE OF PERFORMANCE, ERROR, OMISSION, INTERRUPTION, EFFECT, DELAY IN OPERATION OR TRANSMISSION, COMPUTER VIRUS, LINE SYSTEM FAILURE, LOSS OF DATA, OR LOSS OF USE RELATED TO THE SITE OR ANY WEBSITE OPERATED BY ANY THIRD PARTY, WHETHER BASED ON WARRANTY, CONTRACT, TORT, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT MIRUM IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IF YOU ARE DISSATISFIED WITH US, ANY OF OUR SERVICES OR THESE TERMS OF USE, YOUR SOLE AND EXCLUSIVE REMEDY IS TO DISCONTINUE USE OF THE SITE.

Any claims arising in connection with your use of the site or any content must be brought within one (1) year of the date of the event giving rise to such action occurred.

As a resource to our visitors, this site provides links to other websites. However, because we do not control the content of the other websites we may link to, and due to their constantly changing nature, we cannot be responsible for the content, practices or standards of third-party sites. Mirum does not endorse the content on any third-party websites. Mirum is not responsible for the content of linked third-party sites, sites framed within the site, or third-party advertisements and does not make any representations regarding their content or accuracy. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Everything that you read or see on the site is copyrighted or otherwise protected and owned by Mirum or a third party who licensed or granted to Mirum the right to use such material. Unless otherwise expressly noted, nothing that you read or see on the site may be copied or used except as provided in these Terms of Use or with the prior written approval of Mirum.

We grant you permission to print individual pages from the site, unless otherwise expressly noted, for your own personal, noncommercial use in learning about the services or products offered by Mirum or for your noncommercial use in connection with healthcare or education. If you are a healthcare professional or provider, you may print individual pages from the site, unless otherwise expressly noted, and share the information and materials with others. No other permission is granted to you to print, copy, reproduce, distribute, license, transfer, sell, transmit, upload, download, store, display in public, alter, modify or create derivative works of these materials. This grant of permission is not a transfer of title, and under this permission you may not:

  • use the materials for any commercial purpose, or for any public display (commercial or noncommercial);
  • remove any copyright, trademark or other proprietary notations from the materials; or
  • transfer the materials to another person or “mirror” the materials on any other server.

This website does not provide instruction on the appropriate use of any of Mirum’s products. Information on this website regarding any products approved for marketing is qualified in its entirety by reference to the approved prescribing information for each product. Product information may vary by country. Information about our products that are marketed in the U.S. is intended for use only by residents of the U.S., and information about our products that are marketed outside the U.S. is intended for use only by residents of the countries in which such products are marketed. You should be aware that any product candidates that have not been approved for distribution in a particular country have not been found safe or effective by any regulatory agency of that country and are not approved for use outside of clinical trials in that country. The information presented on this website should not be interpreted or construed in any way as providing medical advice or as a replacement or substitute for medical advice provided by your doctor or health care provider. It is important for you to discuss your treatment options, and any questions that you may have, with your doctor or health care provider. You should not use this website to diagnose or treat a health problem or disease.

We make no warranties or representations to you that your use of any materials displayed on the site will not infringe the rights of third parties.

Unless otherwise indicated, all logos, names, designs, and marks, including all product names, whether or not appearing in large print or with a trademark, on the site are trademarks or service marks owned or used under license by Mirum. The use or misuse of any of these marks or other information is strictly prohibited. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent or trademark of Mirum or any third party.

Except as expressly provided above nothing contained herein shall be construed as conferring any license or right under any Mirum copyright. Except as expressly set forth on the site, if you submit any information to us, including any comments, remarks, suggestions, ideas, notes, drawings, graphics, concepts, or other information, you are giving that information, and all your rights in it, to Mirum free of charge and such information shall be deemed to be nonconfidential and Mirum shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose and distribute the information to others without limitation, without your consent or any compensation to you or anyone else. Mirum shall be free to use any know-how or techniques contained in such information for any purpose whatsoever including but not limited to developing, manufacturing and marketing products incorporating such information. This is true whether you submit such information to us by email, through a form on the site, on a bulletin board, or in any other manner. Mirum may from time to time monitor, review and, in its sole discretion, modify or delete any postings you make on the site; however, Mirum is not obligated to do so.

You agree not to submit or transmit any material that is unlawful, threatening, libelous, defamatory, obscene, pornographic, profane, or might in any other way violate any law, regulation, or rule. You are solely responsible for any material you submit to the site. You further agree not to upload, email, post or transmit to, or distribute or otherwise publish through the site any material which disrupts the normal operation of the site or imposes an unreasonable or disproportionately large load on our network or infrastructure, including posting or otherwise transmitting material that is not related to the subject at issue or otherwise restricts or inhibits any other user from using the site. Through your usage of the site, you may submit and/or Mirum may gather certain limited information about you and your website usage. We are free to use such information for any purpose we deem appropriate, including marketing purposes.

To obtain full access to the site, you may be required to complete a registration. You are responsible for maintaining the confidentiality of your account and password and for restricting access to your computer. You accept responsibility for all activities that occur under your account or password and such use shall be deemed to be use by you. You will ensure that all use of your account fully complies with these Terms of Use. Transfer of the account by you to any other person or entity is prohibited.

When using the site, information will be transmitted over a medium that is beyond the control and jurisdiction of Mirum and its suppliers. Accordingly, Mirum assumes no liability for or relating to the delay, failure, interruption, or corruption of any data or other information transmitted in connection with use of this site.

Mirum is located in California, in the United States of America (USA). This site is intended for the exclusive use of residents of the USA. Mirum makes no representation that the materials on the site are appropriate or available for use in other locations. Access to the content may not be legal by certain persons or in certain countries outside of the USA. If you access this site from outside the United States, you do so at your own risk and are responsible for compliance with the laws of your jurisdiction.

These Terms of Use are governed by the internal substantive laws of the State of California, without resort to its conflict of laws principles. If any provision of these Terms of Use is found to be invalid by any court having competent jurisdiction, the invalidity of such provision shall not affect the validity of the remaining provisions of these Terms of Use. You expressly agree that exclusive jurisdiction for any dispute with Mirum, or in any way relating to your use of this site, resides in the courts of the State of California. Mirum may terminate this agreement, terminate your access to all or part of the site, or suspend any user’s access to all or part of the site, at any time, without notice to you, if it believes, in its sole judgment, that you have breached or may breach any term or condition of this agreement, or for its convenience. You may terminate this agreement at any time by destroying all materials received from the site and ceasing to use the site.

This website may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to Mirum’s future operating or financial performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by such forward-looking statements. Forward-looking statements may include, but are not limited to, statements about Mirum’s prospects, strategies, intentions, plans, objectives and future operating or financial performance, as well as statements about anticipated trends in business and industry and other characterizations of future events or circumstances. When used on this website, terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “seeks,” “should,” “would,” “will” and similar expressions are intended to identify forward-looking statements. These forward-looking statements reflect Mirum’s plans, objectives, estimates, expectations and intentions only as of the date of the document containing the forward-looking statement or as of the dates indicated in the forward-looking statements, and inherently involve significant risks and uncertainties. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Many of these risks and uncertainties are described under the caption “Risk Factors” and elsewhere in Mirum’s Securities and Exchange Commission filings and reports, including in any recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q. Mirum undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made. In addition, this website and the information in this website do not constitute an offer or a solicitation of an offer for sale of any securities. Finally, none of the information contained in this website is intended to be, and shall not be deemed to be, incorporated into any of Mirum’s securities-related filings or documents.

Except as expressly provided in a particular “legal notice” on this site, these Terms of Use constitute the entire agreement between you and Mirum with respect to the use of this site, and content. Your use of this site is also subject to the Privacy Statement.

Without prejudice to your rights under applicable law, Mirum reserves the right to amend these Online Terms of Use to reflect technological advancements, legal and regulatory changes and good business practices. If Mirum changes these Online Terms of Use, an updated version of these Online Terms of Use will reflect those changes. An updated effective date at the top of these Online Terms of Use will constitute notice of such changes. By accessing or using our website, you agree that you have read, understand, and agree to be bound to the current version of these Online Terms of Use, which you may view when accessing the Mirum website. If you disagree with these Online Terms of Use, or are dissatisfied with our website, your sole and exclusive remedy is to discontinue using the Mirum website.

Last Updated: February 5, 2021

Collapse icon

Indication

LIVMARLI is indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 1 year of age and older.

Important Safety Information

Warnings and Precautions

Liver Test Abnormalities: Patients enrolled in clinical trials had abnormal liver tests at baseline. In the main clinical trial, treatment-emergent elevations or worsening of liver tests (ALT, AST or T/DB) relative to baseline were observed. Obtain baseline liver tests and monitor during treatment. Dose reduction or treatment interruption may be considered if abnormalities occur in the absence of other causes. For persistent or recurrent liver test abnormalities, consider treatment discontinuation. Discontinue permanently if a patient progresses to portal hypertension or experiences a hepatic decompensation event.

GI Adverse Reactions: Diarrhea, abdominal pain and vomiting were reported as the most common adverse reactions. If diarrhea, abdominal pain and/or vomiting occur and no other etiologies are found, consider reducing the dose or interrupting LIVMARLI. For diarrhea or vomiting, monitor for dehydration and treat promptly. Consider interrupting LIVMARLI dosing if a patient experiences persistent diarrhea or has diarrhea with accompanying signs and symptoms such as bloody stool, vomiting, dehydration requiring treatment, or fever. Restart LIVMARLI at 190 mcg/kg/day when diarrhea, abdominal pain or vomiting resolve, and increase the dose as tolerated. If they recur upon re-challenge, consider stopping LIVMARLI treatment.

Fat-Soluble Vitamin Deficiency: ALGS patients can have fat-soluble vitamin (FSV) deficiency (vitamins A, D, E, and K) at baseline, and LIVMARLI may affect absorption of FSV. In the main clinical trial, treatment emergent FSV deficiency was reported in 3 (10%) patients during 48 weeks of treatment. Obtain baseline serum levels and monitor during treatment, along with any clinical manifestations. Supplement if deficiency is observed. Consider discontinuing LIVMARLI if FSV deficiency persists or worsens despite adequate FSV supplementation.

Adverse Reactions

The most common adverse reactions (≥5%) are diarrhea, abdominal pain, vomiting, fat-soluble vitamin deficiency, liver test abnormalities, gastrointestinal bleeding and bone fractures.

Drug Interactions

Administer bile acid binding resins at least 4 hours before or 4 hours after administration of LIVMARLI.

A decrease in the absorption of OATP2B1 substrates (eg, statins) due to OATP2B1 inhibition by LIVMARLI in the GI tract cannot be ruled out. Consider monitoring the drug effects of OATP2B1 substrates as needed.

Dosing Information

LIVMARLI should be taken 30 minutes before the first meal of the day. The provided oral dosing dispenser must be used to accurately measure the dose. Any remaining LIVMARLI should be discarded 45 days after first opening the bottle.

Please see full Prescribing Information for LIVMARLI.